MyFinsight
Home
Blog
About
Back
Income Statement
Arbutus Biopharma Corp (ABUS)
Arbutus Biopharma Corp (ABUS)
source: myfinsight.com
Comprehensive (loss) income
-$5,192K
(-307.51%↓ Y/Y)
Interest income
$842K
(-19.19%↓ Y/Y)
Net (loss) income
-$5,143K
(-303.84%↓ Y/Y)
Unrealized loss on
available-for-sale securities
-$49K
(-133.33%↓ Y/Y)
Total other income
$821K
(-20.68%↓ Y/Y)
License
$632K
Collaboration And Contracts
$202K
Non Cash Royalty
$180K
Interest expense
$18K
(-35.71%↓ Y/Y)
Foreign exchange (loss)
gain
-$3K
(-114.29%↓ Y/Y)
(loss) income from
operations
-$5,964K
(-500.81%↓ Y/Y)
Revenues
$1,014K
(-90.56%↓ Y/Y)
Total operating
expenses
$6,978K
(-24.57%↓ Y/Y)
General and
administrative
$3,867K
(16.20%↑ Y/Y)
Research and development
$2,898K
(-47.29%↓ Y/Y)
Change in fair value of
contingent consideration
$213K
(-18.08%↓ Y/Y)
Back